CN117025627A - Tobacco chloride channel protein NtCLC13, and coding gene and application thereof - Google Patents
Tobacco chloride channel protein NtCLC13, and coding gene and application thereof Download PDFInfo
- Publication number
- CN117025627A CN117025627A CN202310785468.5A CN202310785468A CN117025627A CN 117025627 A CN117025627 A CN 117025627A CN 202310785468 A CN202310785468 A CN 202310785468A CN 117025627 A CN117025627 A CN 117025627A
- Authority
- CN
- China
- Prior art keywords
- tobacco
- ntclc13
- gene
- channel protein
- chloride channel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 125
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 103
- 101710128223 Chloride channel protein Proteins 0.000 title claims abstract description 27
- 244000061176 Nicotiana tabacum Species 0.000 title abstract description 14
- 241000208125 Nicotiana Species 0.000 claims abstract description 111
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 44
- 239000013598 vector Substances 0.000 claims abstract description 23
- 238000010362 genome editing Methods 0.000 claims abstract description 19
- 239000000460 chlorine Substances 0.000 claims abstract description 17
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 16
- 230000002829 reductive effect Effects 0.000 claims abstract description 14
- 230000001105 regulatory effect Effects 0.000 claims abstract description 12
- 230000001276 controlling effect Effects 0.000 claims abstract 4
- 239000002773 nucleotide Substances 0.000 claims description 16
- 125000003729 nucleotide group Chemical group 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 15
- 108020004414 DNA Proteins 0.000 claims description 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 10
- 238000012163 sequencing technique Methods 0.000 claims description 9
- 230000002401 inhibitory effect Effects 0.000 claims description 7
- 108091027544 Subgenomic mRNA Proteins 0.000 claims description 5
- 102000053602 DNA Human genes 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- 125000000539 amino acid group Chemical group 0.000 claims description 3
- 238000012216 screening Methods 0.000 claims description 3
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 abstract description 28
- 108091033409 CRISPR Proteins 0.000 abstract description 24
- 238000003209 gene knockout Methods 0.000 abstract description 13
- 238000010354 CRISPR gene editing Methods 0.000 abstract description 12
- 238000005516 engineering process Methods 0.000 abstract description 10
- 241000589158 Agrobacterium Species 0.000 abstract description 9
- 230000037427 ion transport Effects 0.000 abstract description 7
- 238000010367 cloning Methods 0.000 abstract description 6
- 230000004960 subcellular localization Effects 0.000 abstract description 5
- 238000004458 analytical method Methods 0.000 abstract description 4
- 210000000805 cytoplasm Anatomy 0.000 abstract description 4
- 230000033228 biological regulation Effects 0.000 abstract description 2
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 238000011426 transformation method Methods 0.000 abstract 1
- 102000011045 Chloride Channels Human genes 0.000 description 14
- 108010062745 Chloride Channels Proteins 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 150000003839 salts Chemical class 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 238000012408 PCR amplification Methods 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 239000007787 solid Substances 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000000137 annealing Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 230000032258 transport Effects 0.000 description 5
- 108091064523 Clc family Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000008223 sterile water Substances 0.000 description 4
- 230000009261 transgenic effect Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000219194 Arabidopsis Species 0.000 description 3
- 230000004544 DNA amplification Effects 0.000 description 3
- 238000010802 RNA extraction kit Methods 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000003938 response to stress Effects 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000002377 thylakoid Anatomy 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000565357 Fraxinus nigra Species 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 101001040734 Homo sapiens Golgi phosphoprotein 3 Proteins 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 241000207746 Nicotiana benthamiana Species 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001002356 Valeriana edulis Species 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 101150105830 clc gene Proteins 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000003501 hydroponics Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000006870 ms-medium Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Nutrition Science (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Description
技术领域Technical field
本发明涉及烟草氯离子通道蛋白NtCLC13及其编码基因和应用,属于植物基因工程技术领域。The invention relates to tobacco chloride ion channel protein NtCLC13 and its encoding gene and application, and belongs to the technical field of plant genetic engineering.
背景技术Background technique
已有的研究普遍认为,烟叶中的氯离子含量以0.3~0.8为宜,在含量达到1%时会影响阴燃持火性,进一步高于1%时会出现黑灰熄火现象;另一方面,烟叶中氯离子含量过高时会造成淀粉积累多,叶片肥厚而脆,吸湿性大,使得存放时颜色易变深,产生不良气味。总之,烟叶中氯离子含量对于烟叶质量具有较为重要的直接影响。目前,河南、云南等部分烟区烟叶中氯离子含量偏高,降低了烟叶的品质和产量,这成为了种植者和研究人员亟需解决的问题。Existing research generally believes that the chloride ion content in tobacco leaves is preferably 0.3 to 0.8. When the content reaches 1%, it will affect the smoldering fire-holding property. When it is further higher than 1%, black ash flameout will occur; on the other hand, , when the chloride ion content in tobacco leaves is too high, it will cause excessive starch accumulation, the leaves will be thick and brittle, and they are highly hygroscopic, making the color easy to darken during storage and producing bad odor. In short, the chloride ion content in tobacco leaves has an important direct impact on the quality of tobacco leaves. At present, the chloride ion content in tobacco leaves in some tobacco areas such as Henan and Yunnan is relatively high, which reduces the quality and yield of tobacco leaves. This has become an urgent problem for growers and researchers.
传统改善方式多是从栽培技术入手,通过优化田间管理措施、完善调制发酵技术来稳定和提升烟叶品质。但总体而言,这些措施并未从根本上改变这些烟叶质量偏低、工业实用性不强的局面。Traditional improvement methods mostly start with cultivation technology, stabilizing and improving tobacco leaf quality by optimizing field management measures and improving modulation and fermentation technology. But overall, these measures have not fundamentally changed the situation of low quality and low industrial practicality of these tobacco leaves.
随着基因组学尤其是基因编辑技术的快速发展,人们对于烟叶中氯离子积累与相关基因之间的关系认识越来越深入。基于已有研究已经知晓的是:对于氯离子通道蛋白(CLC,Chloride Channel)蛋白家族,拟南芥中有7个成员,研究表明AtCLCa在驱使硝酸盐进入液泡的过程中起到关键作用,而AtCLCb就没有这种功能;其他的AtCLC分布在其他细胞区间,AtCLCd和AtCLCf可能在转运高尔基囊泡网络中起到酸化作用;AtCLCe可能参与类囊体膜的阴离子渗透性;AtCLCg与AtCLCc功能一致,参与植物盐胁迫。2007年Anne Marmagne等人在研究拟南芥CLCf时发现(Two members of the Arabidopsis CLC(chloride channel)family,AtCLCe and AtCLCf,are associated with thylakoid and Golgi membranes,respectively,Journal of Experimental Botany,2007,58(12):3385-3393),AtCLCf定位于高尔基体膜上,并在功能上补充了编码高尔基相关蛋白的单CLC基因中中断的酵母gef1突变体。但总体而言,由于CLC家族蛋白功能的多样化,以及不同物种中CLC家族蛋白功能并不完全一致。仅就烟草品种改良而言,针对烟草中CLC家族蛋白的功能进行深入研究可能为烟草品种改良,甚至可为其他植物改良奠定理论基础和应用基础。因此,挖掘烟草中CLC家族蛋白成员及其相关功能,对调控烟草中氯离子含量、进一步了解氯离子转运的分子调控有重要意义。With the rapid development of genomics, especially gene editing technology, people have a deeper and deeper understanding of the relationship between chloride ion accumulation in tobacco leaves and related genes. Based on existing research, it is already known that there are 7 members of the chloride channel protein (CLC) protein family in Arabidopsis. Studies have shown that AtCLCa plays a key role in driving nitrate into the vacuole, and AtCLCb does not have this function; other AtCLCs are distributed in other cell compartments. AtCLCd and AtCLCf may play an acidifying role in the transport Golgi vesicle network; AtCLCe may be involved in the anion permeability of the thylakoid membrane; AtCLCg has the same function as AtCLCc. Involved in plant salt stress. In 2007, Anne Marmagne et al. discovered when studying Arabidopsis CLCf that (Two members of the Arabidopsis CLC (chloride channel) family, AtCLCe and AtCLCf, are associated with thylakoid and Golgi membranes, respectively, Journal of Experimental Botany, 2007, 58( 12):3385-3393), AtCLCf localizes to the Golgi membrane and functionally complements yeast gef1 mutants disrupted in the single CLC gene encoding Golgi-associated proteins. But in general, due to the diversification of functions of CLC family proteins, and the functions of CLC family proteins in different species are not completely consistent. As far as tobacco variety improvement is concerned, in-depth research on the functions of CLC family proteins in tobacco may lay a theoretical and application basis for tobacco variety improvement and even other plant improvements. Therefore, discovering the members of the CLC family proteins in tobacco and their related functions is of great significance for regulating the chloride ion content in tobacco and further understanding the molecular regulation of chloride ion transport.
发明内容Contents of the invention
为解决上述问题,本发明的第一个目的是提供一种烟草氯离子通道蛋白编码基因NtCLC13基因,该基因能够编码烟草氯离子通道蛋白NtCLC13,进而对烟草中氯离子转运进行调控。In order to solve the above problems, the first purpose of the present invention is to provide a tobacco chloride ion channel protein encoding gene NtCLC13 gene, which can encode the tobacco chloride ion channel protein NtCLC13 and thereby regulate chloride ion transport in tobacco.
本发明的第二个目的是提供一种烟草氯离子通道蛋白NtCLC13,本发明通过实验证明NtCLC13蛋白参与烟草中氯离子的吸收转运,能通过调控该蛋白的表达对烟草中氯离子的含量进行调控。The second object of the present invention is to provide a tobacco chloride ion channel protein NtCLC13. The present invention proves through experiments that the NtCLC13 protein participates in the absorption and transport of chloride ions in tobacco, and can regulate the content of chloride ions in tobacco by regulating the expression of the protein. .
本发明的第三个目的是提供烟草氯离子通道蛋白编码基因NtCLC13基因在调控烟草氯离子转运中的应用,通过实验证明调控NtCLC13基因的表达能影响烟草中氯离子的含量,丰富了烟草中氯离子调控的基因网络。The third object of the present invention is to provide the application of the tobacco chloride channel protein encoding gene NtCLC13 gene in regulating tobacco chloride ion transport. Experiments have proved that regulating the expression of the NtCLC13 gene can affect the content of chloride ions in tobacco and enrich the chlorine content in tobacco. Ion-regulated gene networks.
本发明的第四个目的是提供烟草氯离子通道蛋白编码基因NtCLC13基因在获得低氯烟草品种中的应用,通过CRISPR/Cas9基因编辑技术,将烟草植株中NtCLC13基因敲除,发现敲除株系的叶片中氯离子含量显著下降,获得低氯烟草品种。The fourth object of the present invention is to provide the application of the tobacco chloride channel protein encoding gene NtCLC13 gene in obtaining low-chlorine tobacco varieties. Through CRISPR/Cas9 gene editing technology, the NtCLC13 gene in tobacco plants is knocked out and the knockout strain is found. The chloride ion content in the leaves was significantly reduced, and low-chlorine tobacco varieties were obtained.
为了实现上述目的,本发明烟草氯离子通道蛋白编码基因NtCLC13基因所采用的技术方案是:In order to achieve the above object, the technical solution adopted by the tobacco chloride ion channel protein encoding gene NtCLC13 gene of the present invention is:
一种烟草氯离子通道蛋白编码基因NtCLC13基因,其特征在于:其核苷酸序列为:A tobacco chloride channel protein encoding gene NtCLC13 gene is characterized in that its nucleotide sequence is:
(1)SEQ ID NO.1所示的核苷酸序列;(1) The nucleotide sequence shown in SEQ ID NO.1;
(2)SEQ ID NO.1所示的核苷酸序列经取代和/或缺失和/或添加一个或多个核苷酸且表达相同功能蛋白的核苷酸序列。(2) A nucleotide sequence in which the nucleotide sequence shown in SEQ ID NO. 1 is substituted and/or deleted and/or one or more nucleotides are added and expresses the same functional protein.
上述技术方案的有益效果在于:本发明通过设计特异性引物,克隆获得了烟草氯离子通道蛋白编码基因NtCLC13基因,在烟草中通过抑制其表达,减少氯离子向地上部的转运,说明NtCLC13基因参与调控烟草中氯离子转运的过程。The beneficial effect of the above technical solution is that by designing specific primers, the present invention clones the tobacco chloride ion channel protein encoding gene NtCLC13 gene. By inhibiting its expression in tobacco, the transport of chloride ions to the shoots is reduced, indicating that the NtCLC13 gene is involved. Processes regulating chloride ion transport in tobacco.
为了实现上述目的,本发明烟草氯离子通道蛋白NtCLC13所采用的技术方案是:In order to achieve the above objectives, the technical solution adopted by the tobacco chloride ion channel protein NtCLC13 of the present invention is:
一种烟草氯离子通道蛋白NtCLC13,其氨基酸序列为:A tobacco chloride ion channel protein NtCLC13, its amino acid sequence is:
(1)SEQ ID NO.2所示的氨基酸序列;(1) The amino acid sequence shown in SEQ ID NO.2;
(2)SEQ ID NO.2所示的氨基酸序列经取代和/或缺失和/或添加一个或多个氨基酸残基且功能相同的衍生蛋白。(2) A derivative protein in which the amino acid sequence shown in SEQ ID NO. 2 is substituted and/or deleted and/or one or more amino acid residues are added and has the same function.
上述技术方案的有益效果在于:NtCLC13蛋白被NtCLC13基因编码表达,经验证发现,烟草氯离子通道蛋白NtCLC13与烟草中氯离子吸收转运密切相关,抑制其表达,氯离子的从根部向地上部转运的能力降低,烟草叶片中的氯离子含量显著降低。The beneficial effect of the above technical solution is that the NtCLC13 protein is encoded and expressed by the NtCLC13 gene. It has been verified that the tobacco chloride ion channel protein NtCLC13 is closely related to the absorption and transport of chloride ions in tobacco, inhibiting its expression, and transporting chloride ions from the roots to the shoots. The ability is reduced, and the chloride ion content in tobacco leaves is significantly reduced.
为了实现上述目的,本发明烟草氯离子通道蛋白编码基因NtCLC13基因在调控烟草氯离子转运中的应用所采用的技术方案是:In order to achieve the above purpose, the technical solution adopted in the application of the tobacco chloride ion channel protein encoding gene NtCLC13 gene in regulating tobacco chloride ion transport in the present invention is:
烟草氯离子通道蛋白编码基因NtCLC13基因在调控烟草氯离子转运中的应用。Application of the tobacco chloride channel protein encoding gene NtCLC13 gene in regulating tobacco chloride ion transport.
上述技术方案的有益效果在于:本发明通过CRISPR/Cas9技术获得的NtCLC13基因敲除的烟草植株,NtCLC13基因敲除株在正常培养基中与对照组相比相差不大,加入盐胁迫后,NtCLC13基因敲除株生长与对照组相比明显受到抑制,根长变短,说明NtCLC13基因参与了烟草盐胁迫响应。The beneficial effect of the above technical solution is that the NtCLC13 gene knockout tobacco plants obtained by the present invention through CRISPR/Cas9 technology, the NtCLC13 gene knockout strain is almost the same as the control group in the normal medium. After adding salt stress, NtCLC13 Compared with the control group, the growth of the gene knockout strain was significantly inhibited and the root length was shortened, indicating that the NtCLC13 gene is involved in tobacco salt stress response.
作为进一步地改进,抑制NtCLC13基因的表达,烟草叶片中氯离子的含量显著降低。As a further improvement, by inhibiting the expression of the NtCLC13 gene, the chloride ion content in tobacco leaves was significantly reduced.
上述技术方案的有益效果在于:通过进一步检测发现,NtCLC13基因敲除株的叶片中氯离子含量显著下降,说明抑制NtCLC13基因表达,氯离子的从根部向地上部转运的能力降低。The beneficial effect of the above technical solution is that: through further testing, it was found that the chloride ion content in the leaves of the NtCLC13 gene knockout strain decreased significantly, indicating that the expression of the NtCLC13 gene was inhibited and the ability of chloride ions to be transported from the roots to the shoots was reduced.
为了实现上述目的,本发明烟草氯离子通道蛋白编码基因NtCLC13基因在获得低氯烟草品种中的应用所采用的技术方案是:In order to achieve the above purpose, the technical solution adopted in the application of the tobacco chloride ion channel protein encoding gene NtCLC13 gene in obtaining low-chlorine tobacco varieties of the present invention is:
烟草氯离子通道蛋白编码基因NtCLC13基因在获得低氯烟草品种中的应用,通过抑制NtCLC13基因的表达,降低烟草叶片中的氯离子,获得低氯烟草品种。The application of the tobacco chloride channel protein encoding gene NtCLC13 gene in obtaining low-chlorine tobacco varieties. By inhibiting the expression of the NtCLC13 gene, the chloride ions in tobacco leaves are reduced, and low-chlorine tobacco varieties are obtained.
上述技术方案的有益效果在于:本发明通过CRISPR/Cas9技术,在烟草中敲除NtCLC13基因,抑制其表达,获得NtCLC13基因敲除的烟草植株,检测发现所得的NtCLC13基因敲除株叶片中氯离子含量显著降低,可为培育低氯含量烟草新品种奠定良好基础,同时也为烟叶质量的稳定和卷烟质量的改善提供技术支撑。The beneficial effect of the above technical solution is that: the present invention uses CRISPR/Cas9 technology to knock out the NtCLC13 gene in tobacco, inhibit its expression, and obtain NtCLC13 gene knockout tobacco plants. The detection found that chloride ions were present in the leaves of the obtained NtCLC13 gene knockout strain. The significantly reduced content can lay a good foundation for cultivating new tobacco varieties with low chlorine content, while also providing technical support for stabilizing tobacco leaf quality and improving cigarette quality.
作为进一步地改进,所述抑制NtCLC13基因的表达是构建基因编辑载体,对烟草氯离子通道蛋白编码基因NtCLC13基因进行敲除。As a further improvement, the method of inhibiting the expression of the NtCLC13 gene is to construct a gene editing vector to knock out the tobacco chloride channel protein encoding gene NtCLC13 gene.
上述技术方案的有益效果在于:CRISPR/Cas9技术相较于传统基因干扰等,具有敲除效率高、操作简便的优势。The beneficial effect of the above technical solution is that compared with traditional gene interference, CRISPR/Cas9 technology has the advantages of high knockout efficiency and easy operation.
作为进一步地改进,基因编辑载体通过如下方法获得:将靶位点双链DNA连接至基因编辑空载体上,测序鉴定。As a further improvement, the gene editing vector is obtained by the following method: connecting the double-stranded DNA of the target site to the gene editing empty vector and sequencing for identification.
作为进一步地改进,靶位点双链DNA对应的sgRNA序列为:TCTCGGCGATAGTGCTCCAC。As a further improvement, the sgRNA sequence corresponding to the double-stranded DNA of the target site is: TCTCGGCGATAGTGCTCCAC.
上述技术方案的有益效果在于:使用上述sgRNA能实现烟草中NtCLC13基因的有效敲除,成功构建出NtCLC13基因敲除的烟草植株,为研究NtCLC13基因的功能奠定基础。The beneficial effect of the above technical solution is that the use of the above sgRNA can effectively knock out the NtCLC13 gene in tobacco, successfully construct NtCLC13 gene knockout tobacco plants, and lay the foundation for studying the function of the NtCLC13 gene.
作为进一步地改进,所述低氯烟草品种通过以下方法获得:将基因编辑载体转化农杆菌作为侵染液,再转化烟草,通过筛选、鉴定获得叶片氯离子含量明显下降的烟草品种。As a further improvement, the low-chlorine tobacco variety is obtained by the following method: transforming the gene editing vector into Agrobacterium as the infection solution, then transforming tobacco, and obtaining a tobacco variety with a significantly reduced chloride ion content in the leaves through screening and identification.
附图说明Description of the drawings
图1为本发明实施例3中烟草NtCLC13蛋白的亚细胞定位图;Figure 1 is a subcellular localization map of tobacco NtCLC13 protein in Example 3 of the present invention;
图2为本发明实施例3中NtCLC13基因敲除的靶位点选择示意图;Figure 2 is a schematic diagram of target site selection for NtCLC13 gene knockout in Example 3 of the present invention;
图3为本发明实施例3中NtCLC13基因T0代基因编辑植株敲除靶位点的测序结果图;Figure 3 is a diagram showing the sequencing results of the knockout target site of the NtCLC13 gene T 0 generation gene editing plant in Example 3 of the present invention;
图4为本发明实施例3中NtCLC13基因编辑植株在盐胁迫下的表型;Figure 4 shows the phenotype of NtCLC13 gene-edited plants under salt stress in Example 3 of the present invention;
图5为本发明实施例3中NtCLC13基因编辑植株叶片氯离子含量图(**代表p<0.01)。Figure 5 is a graph showing the chloride ion content in the leaves of NtCLC13 gene-edited plants in Example 3 of the present invention (** represents p<0.01).
具体实施方式Detailed ways
下面结合具体实施例对本发明做进一步的详细说明。除特殊说明之外,各实施例、实验例及对比例中所用的设备和试剂均可从商业途径得到。The present invention will be further described in detail below with reference to specific embodiments. Unless otherwise specified, the equipment and reagents used in each of the examples, experimental examples and comparative examples can be obtained from commercial sources.
生物材料:biomaterials:
烟草品种:K326和中烟100,所使用的种子均由国家烟草基因研究中心提供。Tobacco varieties: K326 and China Tobacco 100, the seeds used are provided by the National Tobacco Gene Research Center.
载体:pCS1300获赠于武汉天问生物科技有限公司;CRISPR/Cas9载体由西南大学家蚕基因组生物学国家重点实验室提供。Vector: pCS1300 was donated from Wuhan Tianwen Biotechnology Co., Ltd.; the CRISPR/Cas9 vector was provided by the State Key Laboratory of Silkworm Genome Biology, Southwest University.
菌株:Trans5α化学感受态细胞,购自北京全式金生物技术有限公司;GV3101农杆菌感受态细胞,购自上海唯地生物技术有限公司;引物的合成和DNA测序由北京六合华大基因科技股份有限公司提供完成。Strains: Trans5α chemically competent cells, purchased from Beijing Quanshijin Biotechnology Co., Ltd.; GV3101 Agrobacterium competent cells, purchased from Shanghai Weidi Biotechnology Co., Ltd.; primer synthesis and DNA sequencing were provided by Beijing Liuhe BGI Technology Co., Ltd. Ltd. offers completion.
实验试剂:RNA提取试剂盒(RNAprep Pure多糖多酚植物总RNA提取试剂盒)、基因组提取试剂盒(多糖多酚植物基因组DNA提取试剂盒)购自天根生化科技(北京)有限公司;荧光定量试剂盒、反转录试剂盒(Transcriptor First Strand cDNA Synthesis Kit)购自瑞士Roche公司;DNA扩增酶,购自北京全式金生物技术有限公司;限制性内切酶BsaI、质粒提取试剂盒和DNA胶回收试剂盒购自宝生物技术有限公司。Experimental reagents: RNA extraction kit (RNAprep Pure polysaccharide and polyphenol plant total RNA extraction kit), genome extraction kit (polysaccharide and polyphenol plant genomic DNA extraction kit) were purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd.; fluorescence quantification Reagent kit, reverse transcription kit (Transcriptor First Strand cDNA Synthesis Kit) was purchased from Roche Company of Switzerland; DNA amplification enzyme was purchased from Beijing Quanshijin Biotechnology Co., Ltd.; restriction endonuclease BsaI, plasmid extraction kit and DNA gel recovery kit was purchased from Bao Biotechnology Co., Ltd.
实验设备:PCR仪Tprofessional Thermocycler,Biometra公司;定量PCR仪LightCycler96,Roche公司。Experimental equipment: PCR instrument Tprofessional Thermocycler, Biometra Company; quantitative PCR instrument LightCycler96, Roche Company.
实施例1烟草氯离子通道蛋白编码基因NtCLC13基因Example 1 Tobacco chloride channel protein encoding gene NtCLC13 gene
本实施例中的烟草氯离子通道蛋白编码基因NtCLC13基因的核苷酸序列为:The nucleotide sequence of the tobacco chloride channel protein encoding gene NtCLC13 gene in this example is:
(1)SEQ ID NO.1所示的核苷酸序列;(1) The nucleotide sequence shown in SEQ ID NO.1;
(2)SEQ ID NO.1所示的核苷酸序列经取代和/或缺失和/或添加一个或多个核苷酸且表达相同功能蛋白的核苷酸序列。(2) A nucleotide sequence in which the nucleotide sequence shown in SEQ ID NO. 1 is substituted and/or deleted and/or one or more nucleotides are added and expresses the same functional protein.
实施例2烟草氯离子通道蛋白NtCLC13Example 2 Tobacco chloride channel protein NtCLC13
本实施例中的烟草氯离子通道蛋白NtCLC13的氨基酸序列为:The amino acid sequence of tobacco chloride channel protein NtCLC13 in this example is:
(1)SEQ ID NO.2所示的氨基酸序列;(1) The amino acid sequence shown in SEQ ID NO.2;
(2)SEQ ID NO.2所示的氨基酸序列经取代和/或缺失和/或添加一个或多个氨基酸残基且功能相同的衍生蛋白。(2) A derivative protein in which the amino acid sequence shown in SEQ ID NO. 2 is substituted and/or deleted and/or one or more amino acid residues are added and has the same function.
实施例3烟草氯离子通道蛋白编码基因NtCLC13基因在获得低氯烟草品种中的应用Example 3 Application of tobacco chloride channel protein encoding gene NtCLC13 gene in obtaining low-chlorine tobacco varieties
本实施例通过PCR成功克隆出NtCLC13基因,亚细胞定位发现烟草NtCLC13蛋白定位于细胞质中,为进一步挖掘其功能,构建NtCLC13基因的基因编辑载体,利用农杆菌转化法将基因编辑载体转化入烟草植株,成功构建了NtCLC13基因敲除的烟草植株。盐胁迫实验发现NtCLC13基因参与了烟草盐胁迫响应,对基因敲除株T1代进行培养,检测发现NtCLC13基因敲除株的叶片中氯离子含量显著下降。具体实施操作如下:In this example, the NtCLC13 gene was successfully cloned through PCR. Subcellular localization found that the tobacco NtCLC13 protein was located in the cytoplasm. In order to further explore its function, a gene editing vector for the NtCLC13 gene was constructed, and the gene editing vector was transformed into tobacco plants using Agrobacterium transformation. , successfully constructed NtCLC13 gene knockout tobacco plants. The salt stress experiment found that the NtCLC13 gene is involved in the response of tobacco to salt stress. The T1 generation of the gene knockout strain was cultured, and the test found that the chloride ion content in the leaves of the NtCLC13 knockout strain was significantly reduced. The specific implementation operations are as follows:
1、氯离子通道蛋白编码基因NtCLC13基因克隆及亚细胞定位1. Cloning and subcellular localization of NtCLC13 gene encoding chloride channel protein
1)NtCLC13基因的克隆1) Cloning of NtCLC13 gene
NtCLC13基因的克隆及获得过程如下所示:The cloning and acquisition process of NtCLC13 gene is as follows:
(1)提取RNA,反转录cDNA(1) Extract RNA and reverse-transcribe cDNA
将K326种子消毒之后接种在MS培养基上进行萌发,发芽两周后,幼苗移栽到盆里,在培养温度为23~26℃的植物培养间进行培养,待烟苗长至六叶一心时转移至1/2MS液体培养基中继续培养,两周后选取根部进行取样,液氮速冻后备用,采用植物RNA提取试剂盒提取烟草根部总RNA。RNA提取时,参考试剂盒说明书操作即可,然后反转录为cDNA备用。Sterilize K326 seeds and then inoculate them on MS medium for germination. Two weeks after germination, the seedlings are transplanted into pots and cultured in a plant culture room with a culture temperature of 23-26°C. When the tobacco seedlings grow to six leaves and one heart Transfer to 1/2MS liquid medium to continue culturing. Two weeks later, the roots were selected for sampling, frozen in liquid nitrogen for later use, and a plant RNA extraction kit was used to extract total RNA from tobacco roots. When extracting RNA, just refer to the instructions of the kit, and then reverse-transcribe it into cDNA for later use.
(2)设计引物,进行PCR扩增(2) Design primers and perform PCR amplification
PCR扩增引物序列如下:The PCR amplification primer sequences are as follows:
NtCLC13-F:5’-ATGACGGGAGGCGAGTAC-3’(SEQ ID NO.3所示);NtCLC13-F: 5’-ATGACGGGAGGCGAGTAC-3’ (shown in SEQ ID NO.3);
NtCLC13-R:5’-CTACATTGAAAAGATGC-3’(SEQ ID NO.4所示)。NtCLC13-R: 5'-CTACATTGAAAGATGC-3' (shown in SEQ ID NO. 4).
以步骤(1)中反转录的cDNA为模板,利用上述引物进行PCR扩增。Use the reverse-transcribed cDNA in step (1) as a template and use the above primers to perform PCR amplification.
PCR扩增体系为:5×GCL buffer 10μL,cDNA 2μL,上下游引物各1μL,dNTP 6μL,GXL DNA Polymerase 1μL,加灭菌水至50μL。The PCR amplification system is: 10 μL of 5×GCL buffer, 2 μL of cDNA, 1 μL of upstream and downstream primers, 6 μL of dNTP, 1 μL of GXL DNA Polymerase, and add sterile water to 50 μL.
PCR扩增条件为:98℃、10sec;55℃、15sec,68℃、2min,30个循环。PCR产物进行琼脂糖电泳检测分析并用参照DNA胶回收试剂盒说明书纯化回收PCR扩增后产物。PCR amplification conditions were: 98°C, 10sec; 55°C, 15sec, 68°C, 2min, 30 cycles. The PCR products were detected and analyzed by agarose electrophoresis, and the PCR amplified products were purified and recovered using the instructions of the DNA gel recovery kit.
纯化产物再连接至pFF19载体上,连接体系如下:DNA扩增产物,6μL;pFF19载体,1μL;混匀后,25℃连接25min。The purified product was then connected to the pFF19 vector. The connection system was as follows: DNA amplification product, 6 μL; pFF19 vector, 1 μL; after mixing, ligation was carried out at 25°C for 25 minutes.
将连接产物转化至大肠杆菌DH5α感受态细胞中,具体转化过程如下所示:Transform the ligation product into E. coli DH5α competent cells. The specific transformation process is as follows:
从-80℃冰箱中取出感受态细胞,置于冰上使其溶解,加连接产物于100μL DH5α感受态细胞中,轻弹混匀,冰浴20min;42℃水浴中热激90s,立即置于冰上2min;加入900μL平衡至室温的LB(不含抗生素)液体培养基,37℃摇荡培养1h;4000rpm离心3min,去部分上清,留100μL将沉淀混匀,均匀地涂布到LB固体平板(含50μg/μL卡那霉素)上,倒置培养皿,37℃培养过夜。Take out the competent cells from the -80°C refrigerator, place them on ice to dissolve, add the ligation product to 100 μL DH5α competent cells, mix gently, and keep in ice bath for 20 minutes; heat shock in 42°C water bath for 90 seconds, and place immediately Place on ice for 2 minutes; add 900 μL of LB (antibiotic-free) liquid culture medium that has been equilibrated to room temperature, shake and culture at 37°C for 1 hour; centrifuge at 4000 rpm for 3 minutes, remove part of the supernatant, leave 100 μL of the precipitate, mix evenly, and spread evenly on the LB solid plate (containing 50 μg/μL kanamycin), invert the culture dish, and culture at 37°C overnight.
翌日,挑单克隆,送出测序。The next day, single clones were selected and sent for sequencing.
测序结果及分析结果表明,NtCLC13基因基因编码区长度为2238bp个核苷酸;对该基因分析后可知,其所编码的NtCLC13蛋白的氨基酸序列如SEQ ID NO.2所示。Sequencing results and analysis results show that the length of the NtCLC13 gene coding region is 2238 bp nucleotides; analysis of the gene shows that the amino acid sequence of the NtCLC13 protein encoded by it is shown in SEQ ID NO. 2.
2)烟草NtCLC13蛋白的亚细胞定位2) Subcellular localization of tobacco NtCLC13 protein
设计引物pCS1300S-NtCLC13F和pCS1300S-NtCLC13R,将NtCLC13克隆到含有GFP标签的pCS1300S载体上,引物序列为:Design primers pCS1300S-NtCLC13F and pCS1300S-NtCLC13R, and clone NtCLC13 into the pCS1300S vector containing GFP tag. The primer sequence is:
pCS1300S-NtCLC13F:5’-GCTTTCGCGAGCTCGGTACCATGACGGGAGGCGAGTAC-3’(SEQ IDNO.5所示);pCS1300S-NtCLC13F: 5'- GCTTTCGCGAGCTCGGTACC ATGACGGGAGGCGAGTAC-3' (shown in SEQ IDNO.5);
pCS1300S-NtCLC13R:5’-CCCTTGCTCACCATGGATCCCATTGAAAAGATGC-3’(SEQ IDNO.6所示)。pCS1300S-NtCLC13R: 5'- CCCTTGCTCACCATGGATCC CATTGAAAAGATGC-3' (shown in SEQ ID NO. 6).
注:划线部分为接头序列。Note: The underlined part is the adapter sequence.
PCR扩增体系和反应程序同第1)部分NtCLC13基因的克隆中PCR扩增体系和反应程序。获得的PCR产物用In-Fusion酶连接至pCS1300载体上,连接体系如下:DNA扩增产物,2μL;pCS1300S载体2μL;In-Fusion酶1μL。混匀后,50℃连接15min。连接产物转化至大肠杆菌DH5α感受态中,挑取单菌落测序。The PCR amplification system and reaction procedures are the same as those in Part 1) Cloning of NtCLC13 gene. The obtained PCR product was connected to the pCS1300 vector using In-Fusion enzyme. The connection system was as follows: DNA amplification product, 2 μL; pCS1300S vector 2 μL; In-Fusion enzyme 1 μL. After mixing, connect at 50°C for 15 minutes. The ligation product was transformed into E. coli DH5α competent cells, and single colonies were picked for sequencing.
测序正确的质粒经质粒大提试剂盒提取高质量质粒,转化本氏烟原生质体,以线粒体marker做对照(红色),结果如图1所示,NtCLC13定位于细胞质中。The correctly sequenced plasmid was extracted with a high-quality plasmid using a plasmid maximization kit and transformed into Nicotiana benthamiana protoplasts. The mitochondrial marker was used as a control (red). The results are shown in Figure 1. NtCLC13 is located in the cytoplasm.
2、基因编辑载体的构建2. Construction of gene editing vectors
为进一步了解NtCLC13基因在烟草氯离子吸收转运中的功能,构建了用于敲除NtCLC13基因的CRISPR/Cas9表达载体,实验过程如下:In order to further understand the function of NtCLC13 gene in tobacco chloride ion absorption and transport, a CRISPR/Cas9 expression vector for knocking out NtCLC13 gene was constructed. The experimental process is as follows:
首先,根据CRISPR/Cas9系统的识别特点设计靶位点,在NtCLC13基因的第1个外显子区域设计20bp的sgRNA靶点序列,如图2所示,sgRNA序列为:TCTCGGCGATAGTGCTCCAC(SEQID NO.7所示),设计敲除引物序列NtCLC13-T1_F和NtCLC13-T1_R如下:First, the target site was designed based on the recognition characteristics of the CRISPR/Cas9 system, and a 20bp sgRNA target sequence was designed in the first exon region of the NtCLC13 gene, as shown in Figure 2. The sgRNA sequence is: TCTCGGCGATAGTGCTCCAC (SEQ ID NO.7 As shown), the design knockout primer sequences NtCLC13-T1_F and NtCLC13-T1_R are as follows:
NtCLC13-T1_F:GTGGAGCACTATCGCCGAGAtgcaccagccgggaat(SEQ ID NO.8所示);NtCLC13-T1_F: GTGGAGCACTATCGCCGAGAtgcaccagccgggaat (shown in SEQ ID NO. 8);
NtCLC13-T1_R:ttctagctctaaaacGTGGAGCACTATCGCCGAGA(SEQ ID NO.9所示)。NtCLC13-T1_R: ttctagctctaaaacGTGGAGCACTATCGCCGAGA (shown in SEQ ID NO. 9).
设计反应体系,以获得靶位点的DNA双链(退火),20μL反应体系设计如下:Annealing Buffer for DNA OLigos(5×),4μL;上下游引物(NtCLC13-T1_F、NtCLC13-T1_R),各4μL(50μmoL/μL);Nuclease-free water补充至20μL。Design the reaction system to obtain the DNA double strand (annealing) of the target site. The 20 μL reaction system is designed as follows: Annealing Buffer for DNA OLigos (5×), 4 μL; upstream and downstream primers (NtCLC13-T1_F, NtCLC13-T1_R), 4 μL each (50μmoL/μL); replenish Nuclease-free water to 20μL.
反应程序为:95℃5min,每8s下降0.1℃,降至25℃;反应产物4℃保存备用,或者直接进行后续反应。The reaction program is: 95°C for 5 minutes, decreasing by 0.1°C every 8 seconds to 25°C; the reaction product is stored at 4°C for later use, or the subsequent reaction can be carried out directly.
将上述退火产物与BsaⅠ酶切后的CRISPR/Cas9载体进行连接,并筛选获得用于敲除NtCLC13基因的CRISPR/Cas9表达载体,20μL连接体系设计如下:退火产物,6μL;酶切产物(BsaⅠ酶切后的CRISPR/Cas9载体),3μL;10×T4 DNA Ligase Buffer,2μL;T4 DNA Ligase,1μL;灭菌水补充至20μL,37℃连接3h。The above annealing product was connected to the CRISPR/Cas9 vector digested by BsaⅠ, and the CRISPR/Cas9 expression vector for knocking out the NtCLC13 gene was screened. The 20 μL connection system was designed as follows: annealing product, 6 μL; enzyme digestion product (BsaⅠ enzyme Cut CRISPR/Cas9 vector), 3 μL; 10×T4 DNA Ligase Buffer, 2 μL; T4 DNA Ligase, 1 μL; add sterile water to 20 μL, and connect at 37°C for 3 hours.
连接产物转化至大肠杆菌感受态细胞中,通过挑取阳性克隆、扩大培养,提取质粒后,经PCR确认载体构建成功后,低温保存,用于农杆菌转化。The ligation product is transformed into E. coli competent cells, and positive clones are picked, expanded and cultured. After the plasmid is extracted, the vector is confirmed to be successfully constructed by PCR and then stored at low temperature for Agrobacterium transformation.
3、转基因植株的获得3. Obtaining transgenic plants
将上述步骤所构建CRISPR/Cas9表达载体转化农杆菌,并进而转化烟草植株,构建NtCLC13基因敲除的转基因植株,实验过程如下:The CRISPR/Cas9 expression vector constructed in the above steps was transformed into Agrobacterium and then into tobacco plants to construct transgenic plants with NtCLC13 gene knockout. The experimental process is as follows:
(1)农杆菌的转化(1) Transformation of Agrobacterium
从-80℃冰箱中取出农杆菌GV3101感受态细胞,在冰上冻融,待即将解冻时加入5μL已经构建好的基因编辑载体,轻弹混匀;冰浴30min,液氮中冻5min,然后在37℃水浴5min后立即放冰上;加入900μL的无抗生素的LB液体培养基,200rpm、振荡培养4h;然后将菌液4500rpm离心3min,弃一半体积的上清,重新悬浮后均匀涂于含有Rif(100μg/mL)、和Kan(50μg/mL)的LB固体培养基上,28℃倒置培养约2~3d,直至单菌落形成;挑取单菌落,扩培后对菌液进行PCR鉴定,鉴定正确的阳性克隆菌株,即为转化正确的工程菌。Take out Agrobacterium GV3101 competent cells from the -80°C refrigerator, freeze and thaw on ice, add 5 μL of the constructed gene editing vector when it is about to thaw, flick to mix; bath in ice for 30 minutes, freeze in liquid nitrogen for 5 minutes, and then Put it on ice immediately after 5 minutes in a 37°C water bath; add 900 μL of antibiotic-free LB liquid culture medium, shake and culture at 200 rpm for 4 hours; then centrifuge the bacterial solution at 4500 rpm for 3 minutes, discard half the volume of the supernatant, resuspend and spread evenly on the On the LB solid medium of Rif (100 μg/mL) and Kan (50 μg/mL), invert the culture at 28°C for about 2 to 3 days until a single colony is formed; pick a single colony, and conduct PCR identification of the bacterial solution after expansion. Identification of the correct positive clone strain is the transformation of the correct engineering bacteria.
(2)转化烟草植株(2) Transform tobacco plants
取生长一个月左右的烟草(中烟100)无菌苗叶片,用打孔器将叶片处理成直径0.5cm大小的叶盘,将处理后叶盘在MS固体培养基上预培养3d;将上述所制备转化后农杆菌工程菌,培养至OD600=0.6左右,4000rpm离心5min收集菌体,再用20mL的MS液体培养基悬浮菌体;然后将上述预培养后叶盘置于菌液中,侵染10min;用无菌的滤纸吸干浸染后叶盘周围多余的菌液,在MS+6-BA(2mg/L)+NAA(0.5mg/L)的固体培养基上暗培养3d;用含有Cef(400mg/L)的无菌水清洗叶盘,并用无菌滤纸吸去多余的液体,将叶盘转到含有6-BA(2mg/L)、NAA(0.5mg/L)、Cef(200mg/L)和Kan(50mg/L)的MS固体筛选培养基上,28℃光照培养;待不定芽长到0.5cm时,转移到含Cef(200mg/L)和Kan(50mg/L)的MS固体培养基上生根。Take the leaves of tobacco (Zhongyan 100) sterile seedlings that have grown for about one month, use a hole punch to process the leaves into leaf discs with a diameter of 0.5cm, and pre-culture the treated leaf discs on MS solid medium for 3 days; The prepared transformed Agrobacterium engineered bacteria were cultured to about OD 600 = 0.6, centrifuged at 4000 rpm for 5 minutes to collect the cells, and then suspended in 20 mL of MS liquid culture medium; then the above-mentioned pre-cultured leaf discs were placed in the bacterial liquid. Infect for 10 minutes; use sterile filter paper to absorb excess bacterial fluid around the leaf disc after infection, and cultivate in the dark for 3 days on a solid medium of MS+6-BA (2mg/L)+NAA (0.5mg/L); use Wash the leaf disc with sterile water containing Cef (400mg/L), absorb excess liquid with sterile filter paper, and transfer the leaf disc to a solution containing 6-BA (2mg/L), NAA (0.5mg/L), Cef ( 200mg/L) and Kan (50mg/L) on MS solid screening medium, culture at 28°C under light; when the adventitious buds grow to 0.5cm, transfer to Cef (200mg/L) and Kan (50mg/L) Roots were grown on MS solid medium.
(3)基因编辑的鉴定(3) Identification of gene editing
待生长一个月左右,取少量叶片,参照植物基因组提取试剂盒说明书提取DNA,通过PCR扩增、克隆、测序的方法,检测阳性转基因株系和突变形式。具体鉴定方法为:After about a month of growth, take a small number of leaves, extract DNA according to the instructions of the plant genome extraction kit, and detect positive transgenic lines and mutant forms through PCR amplification, cloning, and sequencing. The specific identification methods are:
在NtCLC13基因组上,设计一对检测引物,该引物位于敲除靶位点的两侧,具体为:On the NtCLC13 genome, design a pair of detection primers located on both sides of the knockout target site, specifically:
NtCLC13-J-F:5’-GGAGTGAGTACGGTGTGCCAGAAGGCGATTTAGAAAGC-3’(SEQ ID NO.10所示);NtCLC13-J-F: 5’-GGAGTGAGTACGGTGTGCCAGAAGGCGATTTAGAAAGC-3’ (shown in SEQ ID NO. 10);
NtCLC13-J-R:5’-GAGTTGGATGCTGGATGGGCTGAAACTAACCCCGC-3’(SEQ ID NO.11所示)。NtCLC13-J-R: 5'-GAGTTGGATGCTGGATGGGCTGAAAACTAACCCCGC-3' (shown in SEQ ID NO. 11).
以T0代转基因株系DNA模板,进行PCR扩增。PCR amplification was performed using the DNA template of the T 0 generation transgenic strain.
PCR反应体系为:10×buffer 2μL,cDNA 1μL,上下游引物各0.5μL,dNTP 3μL,EazyTaq酶1μL,加灭菌水至20μL。The PCR reaction system is: 2 μL of 10× buffer, 1 μL of cDNA, 0.5 μL of upstream and downstream primers, 3 μL of dNTP, 1 μL of EazyTaq enzyme, and add sterile water to 20 μL.
PCR扩增条件为:94℃预变性4min;94℃变性30s,56℃退火30s,72℃延伸40s,共25个循环;再72℃终延伸10min。PCR产物送Hi-tom测序。PCR amplification conditions were: pre-denaturation at 94°C for 4 min; denaturation at 94°C for 30 s, annealing at 56°C for 30 s, extension at 72°C for 40 s, a total of 25 cycles; and final extension at 72°C for 10 min. The PCR products were sent to Hi-tom sequencing.
分析测序结果如图3所示,在T0代植株中,检测到NtCLC13基因有在敲除的靶位点发生单碱基的缺失突变,而野生型植株的NtCLC13基因未检测到任何突变,这说明在T0代植株中已经成功实现了对NtCLC13基因进行了敲除,编辑植株命名为ntclc13-。The analysis and sequencing results are shown in Figure 3. In the T 0 generation plants, it was detected that the NtCLC13 gene had a single-base deletion mutation at the knockout target site, while no mutation was detected in the NtCLC13 gene of the wild-type plant. This is This shows that the NtCLC13 gene has been successfully knocked out in the T 0 generation plants, and the edited plant is named ntclc13 - .
4、NtCLC13基因编辑植株表型观察4. Phenotypic observation of NtCLC13 gene-edited plants
(1)种子消毒(1)Seed disinfection
将中烟100(对照正常烟草植株)和ntclc13-编辑材料的种子经75%酒精消毒1-2min后用10%NaClO消毒10min,用灭菌水反复冲洗3-5次。The seeds of Zhongyan 100 (control normal tobacco plants) and ntclc13 - edited materials were sterilized with 75% alcohol for 1-2 minutes, then sterilized with 10% NaClO for 10 minutes, and rinsed repeatedly with sterilized water 3-5 times.
(2)盐胁迫表型观察(2) Observation of salt stress phenotypes
将已消毒的种子在加有200mM NaCl的1/2MS固体培养基上播种,不加盐的1/2MS固体培养基做对照,2-3周后观察平板上植株的表型。Sow the sterilized seeds on 1/2MS solid medium with 200mM NaCl added, and use 1/2MS solid medium without salt as a control. Observe the phenotype of the plants on the plate after 2-3 weeks.
结果如图4所示,正常培养基中ntclc13-植株生长与对照相比差别不大,加入盐胁迫后,ntclc13-植株生长与对照相比明显受到抑制,根长变短,说明NtCLC13基因参与了烟草盐胁迫响应。The results are shown in Figure 4. Compared with the control, the growth of ntclc13 - plants in normal medium was not much different. After adding salt stress, the growth of ntclc13 - plants was significantly inhibited compared with the control, and the root length became shorter, indicating that the NtCLC13 gene is involved. Tobacco salt stress response.
5、NtCLC13基因编辑植株叶片氯离子含量检测5. Detection of chloride ion content in leaves of NtCLC13 gene-edited plants
(1)水培试验(1)Hydroponics test
NtCLC13基因编辑植株T1代和对照中烟100植株种植于国家烟草基因研究中心植物培养间,培养条件为:温度(23±1)℃,相对湿度60%±2%,16h光照培养,8h黑暗培养。待烟苗长至六片真叶期,移至Hoagland’s营养液中继续培养,1周后更换一次营养液,再培养3d后取叶片进行后续氯离子含量的测定。叶片经液氮速冻后放-80℃冰箱保存。每个株系设置3个独立重复,每个重复至少选取3株长势一致的烟苗。The T 1 generation of NtCLC13 gene-edited plants and the control Zhongyan 100 plants were planted in the plant culture room of the National Tobacco Gene Research Center. The culture conditions were: temperature (23±1)℃, relative humidity 60%±2%, 16h light culture, 8h dark nourish. When the tobacco seedlings reach the six true leaf stage, they are moved to Hoagland's nutrient solution to continue culturing. The nutrient solution is replaced after 1 week. After another 3 days of cultivation, the leaves are taken for subsequent determination of chloride ion content. The leaves were quickly frozen in liquid nitrogen and then stored in a -80°C refrigerator. Each strain was set up with 3 independent replications, and at least 3 tobacco seedlings with consistent growth were selected for each replication.
(2)氯离子含量测定(2) Determination of chloride ion content
将保存的叶片样品冷冻干燥后,使用混合型振荡研磨仪对其研磨至粉末状,称取约0.0500g(精确至0.1mg)粉末,置于10mL 5%(体积分数)醋酸中,30℃震荡萃取30min,然后用定性滤纸过滤,滤液经稀释后用美国安莱立思Alalis MP6500型台式pH计测定氯离子含量。After freeze-drying the preserved leaf samples, use a mixed oscillating grinder to grind them into powder. Weigh about 0.0500g (accurate to 0.1mg) of the powder, place it in 10mL 5% (volume fraction) acetic acid, and shake at 30°C. Extract for 30 minutes, then filter with qualitative filter paper. After the filtrate is diluted, the chloride ion content is measured with an American Alalis MP6500 desktop pH meter.
结果如图5所示,NtCLC13基因编辑后,叶片中的氯离子含量显著下降(**代表p<0.01)。The results are shown in Figure 5. After NtCLC13 gene editing, the chloride ion content in the leaves significantly decreased (** represents p<0.01).
综上所述,本发明通过对烟草NtCLC13基因的研究,发现NtCLC13蛋白定位在细胞质上;通过基因编辑技术获得NtCLC13基因敲除株,盐胁迫后,ntclc13-编辑植株生长受到抑制,根长与对照相比显著变短;编辑植株叶片中的氯离子含量显著下降,获得了烟叶氯离子含量降低的烟草植株。In summary, the present invention found that the NtCLC13 protein is located in the cytoplasm through research on the tobacco NtCLC13 gene; the NtCLC13 gene knockout strain was obtained through gene editing technology. After salt stress, the growth of ntclc13 -edited plants was inhibited, and the root length was related to the The tobacco plants were significantly shorter than the original ones; the chloride ion content in the leaves of the edited plants was significantly reduced, and tobacco plants with reduced chloride ion content in the leaves were obtained.
最后说明的是:以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention, but not to limit it. Although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand that: The technical solutions described in the foregoing embodiments can be modified, or some or all of the technical features can be equivalently replaced; and these modifications or substitutions do not cause the essence of the corresponding technical solutions to depart from the scope of the technical solutions of the embodiments of the present invention. .
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310785468.5A CN117025627B (en) | 2023-06-29 | 2023-06-29 | Tobacco chloride channel protein NtCLC and coding gene and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310785468.5A CN117025627B (en) | 2023-06-29 | 2023-06-29 | Tobacco chloride channel protein NtCLC and coding gene and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN117025627A true CN117025627A (en) | 2023-11-10 |
| CN117025627B CN117025627B (en) | 2024-11-01 |
Family
ID=88601162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310785468.5A Active CN117025627B (en) | 2023-06-29 | 2023-06-29 | Tobacco chloride channel protein NtCLC and coding gene and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117025627B (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5854411A (en) * | 1997-01-09 | 1998-12-29 | Incyte Pharmaceuticals, Inc. | Human chloride channel |
| US20060075522A1 (en) * | 2004-07-31 | 2006-04-06 | Jaclyn Cleveland | Genes and uses for plant improvement |
| WO2007035650A2 (en) * | 2005-09-16 | 2007-03-29 | Monsanto Technology Llc | Methods for genetic control of insect infestations in plants and compositions thereof |
| CN101054586A (en) * | 2007-03-29 | 2007-10-17 | 上海大学 | Rice chlorine ion passage gene OsCLC, coding protein and clone method thereof |
| WO2014096283A2 (en) * | 2012-12-21 | 2014-06-26 | Philip Morris Products S.A | Tobacco specific nitrosamine reduction in plants |
| CN108841834A (en) * | 2018-06-27 | 2018-11-20 | 中国烟草总公司郑州烟草研究院 | One tobacco chloride channel protein NtCLC2 and its application |
| CN112760329A (en) * | 2021-03-11 | 2021-05-07 | 河南中烟工业有限责任公司 | Tobacco chloride channel protein gene NtCLC-F and application thereof |
| WO2023036691A1 (en) * | 2021-09-10 | 2023-03-16 | Philip Morris Products S.A. | Modulating alkaloid profiles in nicotiana tabacum |
| WO2023117701A1 (en) * | 2021-12-21 | 2023-06-29 | Philip Morris Products S.A. | Modulation of nicotine production by alteration of nicotinamidase expression or function in plants |
-
2023
- 2023-06-29 CN CN202310785468.5A patent/CN117025627B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5854411A (en) * | 1997-01-09 | 1998-12-29 | Incyte Pharmaceuticals, Inc. | Human chloride channel |
| US20060075522A1 (en) * | 2004-07-31 | 2006-04-06 | Jaclyn Cleveland | Genes and uses for plant improvement |
| WO2007035650A2 (en) * | 2005-09-16 | 2007-03-29 | Monsanto Technology Llc | Methods for genetic control of insect infestations in plants and compositions thereof |
| CN101054586A (en) * | 2007-03-29 | 2007-10-17 | 上海大学 | Rice chlorine ion passage gene OsCLC, coding protein and clone method thereof |
| WO2014096283A2 (en) * | 2012-12-21 | 2014-06-26 | Philip Morris Products S.A | Tobacco specific nitrosamine reduction in plants |
| CN108841834A (en) * | 2018-06-27 | 2018-11-20 | 中国烟草总公司郑州烟草研究院 | One tobacco chloride channel protein NtCLC2 and its application |
| CN112760329A (en) * | 2021-03-11 | 2021-05-07 | 河南中烟工业有限责任公司 | Tobacco chloride channel protein gene NtCLC-F and application thereof |
| WO2023036691A1 (en) * | 2021-09-10 | 2023-03-16 | Philip Morris Products S.A. | Modulating alkaloid profiles in nicotiana tabacum |
| WO2023117701A1 (en) * | 2021-12-21 | 2023-06-29 | Philip Morris Products S.A. | Modulation of nicotine production by alteration of nicotinamidase expression or function in plants |
Non-Patent Citations (5)
| Title |
|---|
| HUI ZHANG等: "Identification and analysis of the chloride channel gene family members in tobacco (Nicotiana tabacum)", GENE, vol. 676, 26 June 2018 (2018-06-26), pages 56 - 64 * |
| NCBI: "PREDICTED: Nicotiana tabacum chloride channel protein CLC-f-like (LOC1 07798879), transcript variant X2, mRNA", GENBANK DATABASE, 3 May 2016 (2016-05-03), pages 01 * |
| 康敏华;陈暖;杜喜玲;刘特;刘志学;: "水稻氯离子通道蛋白基因的克隆及表达分析", 西北植物学报, no. 04, 15 April 2011 (2011-04-15), pages 647 - 650 * |
| 张慧;金立锋;徐国云;翟妞;刘萍萍;陈千思;郑庆霞;陈霞;周会娜;: "烟草慢阴离子通道蛋白基因NtSLAH1的克隆及表达分析", 烟草科技, no. 03, 30 March 2018 (2018-03-30), pages 1 - 6 * |
| 王亚宁;张翔;范艺宽;李亮;毛家伟;司贤宗;: "烟草氯素营养研究进展与展望", 中国农学通报, no. 27, 25 September 2017 (2017-09-25), pages 66 - 70 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117025627B (en) | 2024-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019297209B2 (en) | Method of obtaining multi-leaf alfalfa material by means of MsPALM1 artificial site-directed mutant | |
| US20250027100A1 (en) | USE OF MfERF026 GENE REGULATION IN GROWTH, DEVELOPMENT, AND STRESS TOLERANCE OF MEDICAGO SATIVA | |
| CN116218876A (en) | A gene OsB12D3 regulating rice chalkiness and its encoded protein and application | |
| CN117431256B (en) | Wheat yellow mosaic disease-resistant gene TaRx-2D, protein encoded by same and application thereof | |
| CN116143890B (en) | Application of SlGSK8 gene in regulating and controlling color of fruit shoulder of tomato fruit | |
| CN117362406A (en) | Protein HTT7 capable of improving high temperature tolerance of rice in seedling stage and spike stage simultaneously, coding gene and application | |
| CN117534743A (en) | OsJAB1 protein and application thereof in improving salt stress tolerance of rice | |
| CN102690341A (en) | Plant tillering related protein and coding gene thereof | |
| CN117646008A (en) | Gene OsHTG8 for improving rice seedling stage high temperature tolerance and encoding protein and application thereof | |
| CN114457094B (en) | A peony PoAGL15 gene and its amino acid sequence and application | |
| CN116590335A (en) | Application of GSK3 family homologous gene in regulation and control of tomato fruit shape | |
| CN114292855B (en) | PagARR9 gene for regulating and controlling growth of xylem of poplar and application thereof | |
| CN116083429A (en) | miRNA for promoting poplar stem elongation and high growth and application thereof | |
| CN108424910B (en) | A kind of RNA fragment for target gene interference and its application | |
| CN117025626A (en) | Tobacco nitrate transporter NtNPF7.4, encoding gene thereof, gene editing vector and application | |
| CN117025627B (en) | Tobacco chloride channel protein NtCLC and coding gene and application thereof | |
| CN117866066A (en) | PheWOX13-1 protein related to root development of bamboo and its encoding gene and its application | |
| CN117646028A (en) | Application of knockout BnaA05.RLK902 gene in improvement of plant sclerotinia resistance and gray mold and molecular marker | |
| CN115700281B (en) | Rice OsRGE gene and encoding protein and application thereof | |
| CN117534744A (en) | Shennong chrysanthemum transcription factor ChiMYB44 and application thereof | |
| CN113755520B (en) | Semi-dwarf banana gene editing vector and its construction method and application | |
| CN117106798A (en) | Application of PeLAP1 gene in promoting branching of ‘Nanlin 895 Populus’ | |
| CN117305302A (en) | Promoter and application of low boron responsive gene BnaC4.BOR2 in rapeseed | |
| CN113416735A (en) | Tobacco germ cell specific high expression gene and application thereof | |
| CN119220595B (en) | Tobacco NtD27 gene and its application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |